Tutorials
NAS:BNTX (Germany)  
BioNTech SE logo

BioNTech SE

$ 183.11 +2.67 (+1.48%) 10:08 PM EST
P/E:
3.10
P/B:
2.54
Market Cap:
$ 44.50B
Enterprise V:
$ 38.37B
Volume:
1.57M
Avg Vol (2M):
1.08M
Also Trade In:
Volume:
1.57M
Market Cap $:
44.50B
PE Ratio:
3.10
Avg Vol (2-Month):
1.08M
Enterprise Value $:
38.37B
PB Ratio:
2.54
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Name Current Vs Industry Vs History
Cash-To-Debt 33.15
Equity-to-Asset 0.78
Debt-to-Equity 0.01
Debt-to-EBITDA 0.01
Interest Coverage 2092.42
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.71
Distress
Grey
Safe
Beneish M-Score 5.75
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 84.69
9-Day RSI 74.47
14-Day RSI 68.33
6-1 Month Momentum % -8.8
12-1 Month Momentum % -60.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.05
Quick Ratio 4.93
Cash Ratio 1.6
Days Inventory 26.42
Days Sales Outstanding 140.93
Days Payable 13.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.3

Financials (Next Earnings Date:2022-08-08)

BNTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BNTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 26,829.21
EPS (TTM) ($) 58.988
Beta 0
Volatility % 64.27
14-Day RSI 68.33
14-Day ATR ($) 7.328277
20-Day SMA ($) 165.2675
12-1 Month Momentum % -60.23
52-Week Range ($) 117.08 - 464
Shares Outstanding (Mil) 243.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioNTech SE Filings

Document Form Filing Date
No Filing Data

Headlines

See More